GLAXOSMITH Stock Overview
GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes of consumer healthcare and pharmaceutical products in Nigeria.
GlaxoSmithKline Consumer Nigeria Plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₦6.15|
|52 Week High||₦8.50|
|52 Week Low||₦5.40|
|1 Month Change||6.96%|
|3 Month Change||4.24%|
|1 Year Change||8.85%|
|3 Year Change||6.03%|
|5 Year Change||-72.96%|
|Change since IPO||41.31%|
Recent News & Updates
|GLAXOSMITH||NG Pharmaceuticals||NG Market|
Return vs Industry: GLAXOSMITH underperformed the NG Pharmaceuticals industry which returned 20.8% over the past year.
Return vs Market: GLAXOSMITH exceeded the NG Market which returned 3.2% over the past year.
|GLAXOSMITH Average Weekly Movement||3.1%|
|Pharmaceuticals Industry Average Movement||4.4%|
|Market Average Movement||5.3%|
|10% most volatile stocks in NG Market||7.2%|
|10% least volatile stocks in NG Market||3.2%|
Stable Share Price: GLAXOSMITH is less volatile than 75% of NG stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: GLAXOSMITH's weekly volatility (3%) has been stable over the past year.
About the Company
GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes of consumer healthcare and pharmaceutical products in Nigeria. It operates through two segments, Consumer Healthcare and Pharmaceuticals. The Consumer Healthcare segment offers oral care, over-the-counter (OTC) medicine, and nutritional healthcare products.
GlaxoSmithKline Consumer Nigeria Plc Fundamentals Summary
|GLAXOSMITH fundamental statistics|
Is GLAXOSMITH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|GLAXOSMITH income statement (TTM)|
|Cost of Revenue||₦19.44b|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.85|
|Net Profit Margin||3.86%|
How did GLAXOSMITH perform over the long term?See historical performance and comparison